Avadel Pharmaceuticals ADR

TIG Advisors disclosed a 4.18% stake in Avadel Pharmaceuticals, holding 4,102,946 common shares. On January 15 the firm acquired 251,499 shares at prices between $21.50 and $21.53 per share. The filing states that TIG Advisors holds no short positions or Avadel‑related derivatives; no tender offer was indicated. » Plus sur de.investing.com

Morgan Stanley & Co. International plc stated in a mandatory notification to the Irish Takeover Panel that on 14 January 2026 it, as an exempt principal trader, acquired and subsequently disposed of 327 ordinary shares of Avadel Pharmaceuticals. The transactions took place at prices between $21.4931 and $21.5440 per share. The disclosure notes a connection between Morgan Stanley and Avadel Pharmaceuticals; no additional derivative transactions or options were reported. The filing was made under Rule 38 of the Irish Takeover Rules to ensure transparency in potential takeover situations. » Plus sur de.investing.com

FIL and its subsidiaries hold a total of 3,063,023 ordinary shares of Avadel Pharmaceuticals as of the record date January 13, 2026, representing a 3.14% stake. The mandatory notification also cites a recent transaction to purchase 80,000 ordinary shares at USD 21.50 each. There are no agreements or option arrangements between the reporting parties and other companies; the holding was disclosed under Rule 8.3 of the Irish Takeover Panel. » Plus sur de.investing.com